tbResList Print — CET cetuximab
Filters:
qv=5, qv2=%, rfv=%
Product
CET cetuximab
Features:
antineoplastic drug
Description:
<b>Cetuximab</b> a genetically engineered monoclonal antibody (IV): inhibit tumor growth for colorectal cancer, head and neck cancer. <br>
Cardiopulmonary arrest side effect. <br>
Pathway results for Effect on Cancer / Diseased Cells
Total Targets:
0
Pathway results for Effect on Normal Cells
Total Targets:
0
Research papers
Year
Title
Authors
PMID
Link
Flag